Vendor source
Reviewed 11 May 2026
Completeness Strong (78%)
icobrain ep helps physicians with the detection of hippocampal sclerosis in patients with intractable (uncontrollable) epilepsy.
The icobrain ep software aids the assessment of hippocampal asymmetry and, therefore, aids the detection of hippocampal sclerosis, a common cause of intractable epilepsy.
icobrain ep uncovers abnormality patterns by:
Comparing hippocampal asymmetry to an age-and-sex matched normative healthy population.
Assessing the juxtacortical abnormalities (which can indicate cortical malformations).
No papers to support — we monitor for new evidence.
General Information
Product name
Company
Modality
Main task
Not specified
Subspeciality
Disease targeted
Regulatory Information
Pathway:
MDR
Class:
Class I
Verified by Health AI Register
Pathway:
510(k) cleared
Class:
Class II
Verified by Health AI Register
Other certifications
Not specified
Evidence & Research
No research papers or evidence on file yet.
The registry monitors publications for new evidence.
Technical Specifications
Patient population age
Not specified
Input
Input format
Output
Output format
Integration
Deployment
Trigger for analysis
Processing time
Population
Market Presence
On market since
AI Platforms
Resellers
Not specified
Countries present
Paying clinical customers
Research/test users
Pricing Information
Pricing model
Based on
Source: Vendor | First published: May 26, 2024 | Last updated: May 11, 2026